Worth The Extra Expense: PhRMA Makes Drug Cost-Effectiveness Case In New Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Group says new drugs’ higher costs greatly outweighed by decline in other healthcare spending, greater life expectancy.